For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Placebo | the placebo group were given 10g soy protein isolated without isoflavones | None | None | 0 | 54 | 4 | 54 | View |
| Daidzein | Daidzein group were given 10g soy protein isolated and 50mg purify daidzein | None | None | 0 | 55 | 4 | 55 | View |
| Genistein | Genistein group were given 10g soy protein isolated and 50mg purify genistein | None | None | 0 | 56 | 2 | 56 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| vignal bleeding | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |
| hyperplasia of mammary glands | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| proteinuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| thirsty | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| flatulence | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |